Photo by juanantia from unsplash
This cross-sectional study examines how often and in what combinations 4 US Food and Drug Administration programs for expedited development and review of novel drugs were used among orphan and… Click to show full abstract
This cross-sectional study examines how often and in what combinations 4 US Food and Drug Administration programs for expedited development and review of novel drugs were used among orphan and nonorphan biologics and small-molecule drugs approved between 2008 and 2021.
Keywords:
novel drugs;
food drug;
orphan nonorphan;
drug administration;
drug;
development review
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!